Browse by Medical Category
Welcome! CDGEMM stands for Celiac Disease Genomic Environmental Microbiome and Metabolomic Study and enrolls infants who have a first-degree relative with celiac disease.
A versatile team of doctors and scientists at the Center for Celiac Research at Massachusetts General Hospital, MassGeneral Hospital for Children, and the Celiac Program at Harvard Medical School created the CDGEMM study to learn more about each of the many factors that contribute to the development of celiac disease. This long-term, multi-center study will follow infants from birth through childhood with visits that can be conducted at your local pediatrician’s office. Infants can even be enrolled before birth! Explore our website to learn more about how you can get involved!
The CDGEMM Study is currently recruiting infants in the womb or aged up to 6 months who have a first-degree relative (parent or sibling) with celiac disease.
For general questions about the CDGEMM study, email CDGEMM@mgh.harvard.edu. To enroll, or inquire about enrollment, please contact a participating center nearest you.
For study updates and more information from the Center for Celiac Research, visit our website, Facebook and Twitter pages! You can also find details about the CDGEMM study on clinicaltrials.gov and on the Partners Healthcare clinical trials registration page.
Interested in sharing information about CDGEMM in your healthcare setting?
This flyer can be posted or distributed freely to any interested care providers or potential participants. Thank you for helping to spread the word about CDGEMM!
Back to Top